Regier DA - Search Results

1

Health economic evaluation: a primer for the practicing rheumatologist.

Tan MC, Regier DA, Esdaile JM, Lynd LD, Anis AH, Marra CA. Tan MC, et al. Among authors: regier da. Arthritis Rheum. 2006 Aug 15;55(4):648-56. doi: 10.1002/art.22105. Arthritis Rheum. 2006. PMID: 16874788 Free article. Review. No abstract available.

2

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists.

Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, Anis AH, Marra CA. Bansback NJ, et al. Among authors: regier da. Drugs. 2005;65(4):473-96. doi: 10.2165/00003495-200565040-00004. Drugs. 2005. PMID: 15733011 Review.

3

Evaluating health-related quality-of-life studies in paediatric populations: some conceptual, methodological and developmental considerations and recent applications.

De Civita M, Regier D, Alamgir AH, Anis AH, Fitzgerald MJ, Marra CA. De Civita M, et al. Pharmacoeconomics. 2005;23(7):659-85. doi: 10.2165/00019053-200523070-00003. Pharmacoeconomics. 2005. PMID: 15987225 Review.

4

Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy.

Regier DA, Sunderji R, Lynd LD, Gin K, Marra CA. Regier DA, et al. CMAJ. 2006 Jun 20;174(13):1847-52. doi: 10.1503/cmaj.051104. CMAJ. 2006. PMID: 16785459 Free PMC article.

5

Bayesian and classical estimation of mixed logit: An application to genetic testing.

Regier DA, Ryan M, Phimister E, Marra CA. Regier DA, et al. J Health Econ. 2009 May;28(3):598-610. doi: 10.1016/j.jhealeco.2008.11.003. Epub 2008 Dec 3. J Health Econ. 2009. PMID: 19345433

6

Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children.

Regier DA, Friedman JM, Makela N, Ryan M, Marra CA. Regier DA, et al. Clin Genet. 2009 Jun;75(6):514-21. doi: 10.1111/j.1399-0004.2009.01193.x. Clin Genet. 2009. PMID: 19508416

7

Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability.

Regier DA, Friedman JM, Marra CA. Regier DA, et al. Am J Hum Genet. 2010 May 14;86(5):765-72. doi: 10.1016/j.ajhg.2010.03.009. Epub 2010 Apr 15. Am J Hum Genet. 2010. PMID: 20398885 Free PMC article.

8

Economic evaluations of anticoagulants for the prophylaxis of venous thromboembolism following major trauma.

Regier DA, Marra CA, Lynd L. Regier DA, et al. Expert Rev Pharmacoecon Outcomes Res. 2007 Aug;7(4):403-13. doi: 10.1586/14737167.7.4.403. Expert Rev Pharmacoecon Outcomes Res. 2007. PMID: 20528423

9

Cost-effectiveness of tumor necrosis factor-alpha antagonists in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

Regier DA, Bansback N, Dar Santos A, Marra CA. Regier DA, et al. Expert Rev Pharmacoecon Outcomes Res. 2007 Apr;7(2):155-69. doi: 10.1586/14737167.7.2.155. Expert Rev Pharmacoecon Outcomes Res. 2007. PMID: 20528442

10

Health-care practitioners' preferences for the return of secondary findings from next-generation sequencing: a discrete choice experiment.

Jiang S, Anis AH, Cromwell I, Mohammadi T, Schrader KA, Lucas J, Armour CM, Clausen M, Bombard Y, Regier DA. Jiang S, et al. Among authors: regier da. Genet Med. 2020 Dec;22(12):2011-2019. doi: 10.1038/s41436-020-0927-x. Epub 2020 Aug 21. Genet Med. 2020. PMID: 32820245 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

256 results

Search Page